Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 28, 2002
Dendritic cells in vaccination therapies of malignant diseasesPeter Brossart, Peter Brossart M D
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2020
The Role of Antigen Spreading in the Efficacy of ImmunotherapiesPeter Brossart
Journal for Immunotherapy of Cancer|June 11, 2021
T follicular helper cells: linking cancer immunotherapy and immune-related adverse eventsDirk Baumjohann, Peter Brossart
Stem Cells (Dayton, Ohio)|July 28, 2004
Cellular immunotherapy with dendritic cells in cancer: current statusAlessio Nencioni, Peter Brossart
Blood|May 30, 2015
A party of three: iNKT cells in GVHD preventionAnnkristin Heine, Peter Brossart
Current Hematology Reports|December 22, 2004
Current status of vaccination therapy for leukemiasVolker L Reichardt, Peter Brossart
Methods in Molecular Medicine|December 9, 2004
Dendritic cells in clinical trials for multiple myelomaVolker L Reichardt, Peter Brossart
Cytotherapy|February 27, 2004
DC-based immunotherapy of B-cell malignanciesV L Reichardt, Peter Brossart
Cancer Immunology, Immunotherapy : CII|April 11, 2009
Vaccination strategies in patients with renal cell carcinomaAnne Marie Asemissen, Peter Brossart
Expert Opinion on Drug Metabolism & Toxicology|April 18, 2013
Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumorsSavita Bisht, Georg Feldmann, Peter Brossart
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 28, 2002
Dendritic cells in vaccination therapies of malignant diseasesPeter Brossart, Peter Brossart M D
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2020
The Role of Antigen Spreading in the Efficacy of ImmunotherapiesPeter Brossart
Journal for Immunotherapy of Cancer|June 11, 2021
T follicular helper cells: linking cancer immunotherapy and immune-related adverse eventsDirk Baumjohann, Peter Brossart
Stem Cells (Dayton, Ohio)|July 28, 2004
Cellular immunotherapy with dendritic cells in cancer: current statusAlessio Nencioni, Peter Brossart
Blood|May 30, 2015
A party of three: iNKT cells in GVHD preventionAnnkristin Heine, Peter Brossart
Current Hematology Reports|December 22, 2004
Current status of vaccination therapy for leukemiasVolker L Reichardt, Peter Brossart
Methods in Molecular Medicine|December 9, 2004
Dendritic cells in clinical trials for multiple myelomaVolker L Reichardt, Peter Brossart
Cytotherapy|February 27, 2004
DC-based immunotherapy of B-cell malignanciesV L Reichardt, Peter Brossart
Cancer Immunology, Immunotherapy : CII|April 11, 2009
Vaccination strategies in patients with renal cell carcinomaAnne Marie Asemissen, Peter Brossart
Expert Opinion on Drug Metabolism & Toxicology|April 18, 2013
Pharmacokinetics and pharmacodynamics of sunitinib for the treatment of advanced pancreatic neuroendocrine tumorsSavita Bisht, Georg Feldmann, Peter Brossart
Pageof 27